Budget impact of Paxlovid
Published: 9 June 2022| Version 1 | DOI: 10.17632/gvnhbw6m7k.1
Contributor:
Núcleo de Avaliação de Tecnologias em Saúde Instituto Nacional de CardiologiaDescription
Analysis of the Budgetary impact of paxlovid for the treatment of adults who do not require supplemental oxygen and who are at increased risk for progression to severe coronavirus disease 2019 (COVID-19) in Brazil Health System
Files
Institutions
Instituto Nacional de Cardiologia
Categories
Economic Analysis